Magavern, E F, Kaski, J C, Turner, R M, Drexel, H, Janmohamed, A, Scourfield, A, Burrage, D, Floyd, C N, Adeyeye, E, Tamargo, J, Lewis, B S, Kjeldsen, K P, Niessner, A, Wassmann, S, Sulzgruber, P, Borry, P, Agewall, S, Semb, A G, Savarese, G, Pirmohamed, M & Caulfield, M J 2022, ' Challenges in Cardiovascular Pharmacogenomics Implementation : A viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 8, no. 1, pp. 100-103 . https://doi.org/10.1093/ehjcvp/pvab063 EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY
RECOVERY Collaborative Group & Downey, D 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5 LANCET Mumford, A, Ramanan, A V & Gibbison, B J J & Welch, H F 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5, https://doi.org/10.1016/S0140-6736(21)00149-5 The Lancet RECOVERY Collaborative Group, Felton, T, Evans, D G, Murray, C, Buch, M & Dark, P 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5